REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 11,930
+530 (4.65%)
At close: Feb 20, 2026
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 218.81 billion as of February 20, 2026. Its market cap has decreased by -10.23% in one year.
Market Cap
218.81B
Enterprise Value
424.51B
Revenue
149.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,930.00
Market Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 218.81B, an increase of 32.97%. That is a compound annual growth rate of 1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 209.09B | 5.75% |
| Dec 30, 2025 | 197.72B | -16.04% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daewon Pharmaceutical | 251.20B |
| Chong Kun Dang Holdings | 249.93B |
| Samjin Pharmaceuticals | 237.80B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| HLB Pharmaceutical | 227.34B |
| Samil Pharmaceutical Co.,Ltd | 222.49B |
| AptaBio Therapeutics | 220.53B |
| Jeil Pharmaceutical Co.,Ltd | 215.66B |